Lucy Boyle

540 total citations
3 papers, 19 citations indexed

About

Lucy Boyle is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Lucy Boyle has authored 3 papers receiving a total of 19 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Lucy Boyle's work include PARP inhibition in cancer therapy (2 papers), DNA Repair Mechanisms (2 papers) and BRCA gene mutations in cancer (2 papers). Lucy Boyle is often cited by papers focused on PARP inhibition in cancer therapy (2 papers), DNA Repair Mechanisms (2 papers) and BRCA gene mutations in cancer (2 papers). Lucy Boyle collaborates with scholars based in United Kingdom. Lucy Boyle's co-authors include Susan Dutton, Anna Schuh, Corran Roberts, Ruth Clifford, Toby A. Eyre, Shibani Nicum, Marcia Hall, Christopher Poole, Anne Francis and Charlie Gourley and has published in prestigious journals such as Journal of Clinical Oncology and BMC Cancer.

In The Last Decade

Lucy Boyle

3 papers receiving 19 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lucy Boyle United Kingdom	2	8	8	6	6	3	3	19
Alexander Wald Germany	3	9 1.1×	10 1.3×	4 0.7×	6 1.0×		8	22
M Silva Spain	1	8 1.0×	9 1.1×	7 1.2×	8 1.3×		2	22
Neil Dalal United States	3	8 1.0×	9 1.1×	4 0.7×	7 1.2×	1 0.3×	9	31
Haimei Xing China	2	10 1.3×	9 1.1×	8 1.3×	7 1.2×		3	21
Nusayhah Hudaa Gopee United Kingdom	2	10 1.3×	11 1.4×	3 0.5×	9 1.5×	3 1.0×	3	32
Yuping Li United States	4	13 1.6×	7 0.9×	2 0.3×	8 1.3×	2 0.7×	8	24
Sophie A. Herbst Germany	3	7 0.9×	7 0.9×	8 1.3×	3 0.5×		5	21
M Sopena Spain	3	5 0.6×	5 0.6×	13 2.2×	5 0.8×		7	23
Giuseppina Cabras Australia	2	12 1.5×	5 0.6×	2 0.3×	3 0.5×	2 0.7×	2	19
Katrina Kao United States	2	6 0.8×	12 1.5×	4 0.7×	9 1.5×		2	21

Countries citing papers authored by Lucy Boyle

Since Specialization

Citations

This map shows the geographic impact of Lucy Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Boyle more than expected).

Fields of papers citing papers by Lucy Boyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Boyle. The network helps show where Lucy Boyle may publish in the future.

Co-authorship network of co-authors of Lucy Boyle

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Boyle. A scholar is included among the top collaborators of Lucy Boyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Boyle. Lucy Boyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Eyre, Toby A., Ruth Clifford, Corran Roberts, et al.. (2015). Single arm NCRI phase II study of CHOP in combination with Ofatumumab in induction and maintenance for patients with newly diagnosed Richter’s syndrome. BMC Cancer. 15(1). 52–52. 8 indexed citations

2.

Nicum, Shibani, Corran Roberts, Lucy Boyle, et al.. (2014). A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol. BMC Cancer. 14(1). 983–983. 10 indexed citations

3.

Nicum, Shibani, Claire Brooks, Rose Wharton, et al.. (2013). Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.. Journal of Clinical Oncology. 31(15_suppl). TPS5615–TPS5615. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact